Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v8-EN
Language English English
Date Updated 2017-08-10 2017-04-13
Drug Identification Number 02382075 02382075
Brand name MYLAN-BUPROPION XL MYLAN-BUPROPION XL
Common or Proper name BUPROPION XL Bupropion XL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE
Strength(s) 150MG 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 90BT 90s
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-04-14
Actual start date 2017-08-09
Estimated end date 2017-09-30
Actual end date 2017-04-11
Shortage status Actual shortage Avoided shortage
Tier 3 Status No No
Company comments
Health Canada comments